Patrick Gibbons | September 18, 2018
For the past six years, the Indianapolis-based Walther Cancer Foundation has funded research at the University of Notre Dame’s Harper Cancer Research Institute that has led to important discoveries in the early detection of and novel treatments for cancer.
To date, the foundation has provided nearly $9.5 million to support research at the institute to explore bioanalytical approaches for molecular detection of cancer in tissues; evaluate tumor development, progression and metastasis; and use multidimensional imaging to better understand the structure of cancer cells.
Now, in an effort to help extend and expand the Harper Institute’s research programs, the Walther Foundation has made a $3.5 million matching-fund gift that it hopes will inspire those with a similar passion to support novel, multidisciplinary approaches to cancer research.
“The Walther Foundation has been a vital partner and supporter of our work at the institute since our inception,” said Sharon Stack, Kleiderer-Pezold Professor of Biochemistry and the Ann F. Dunne and Elizabeth M. Riley Director of the Harper Cancer Research Institute. “This gift not only represents an endorsement of the institute’s work, but also provides further evidence of the Walther Foundation’s broad-based commitment to support novel approaches to cancer research.”
“The most recent commitment by the Walther Cancer Foundation provides continued funding to the Harper Cancer Research Institute, reflecting our belief in the interdisciplinary approach to cancer research at Harper,” said foundation president and CEO Thomas W. Grein. “This was on full display via poster presentations at a recent Harper Research Day. We saw teams of researchers which could include representatives from the Departments of Biological Sciences, Chemistry, Biochemistry, Chemical and Biomedical Engineering, Mechanical Engineering, Electrical Engineering, and Biomedical Informatics, to name a few. Collaborative research is real at Harper.”
Read more here.